0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mycoplasma Pneumoniae ELISA Kits Market Research Report 2026
Published Date: 2026-04-17
|
Report Code: QYRE-Auto-39K16759
Home | Market Reports | Health| Pharmacy
Global Mycoplasma Pneumoniae ELISA Kits Market Research Report 2024
BUY CHAPTERS

Global Mycoplasma Pneumoniae ELISA Kits Market Research Report 2026

Code: QYRE-Auto-39K16759
Report
2026-04-17
Pages:131
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Mycoplasma Pneumoniae ELISA Kits Market

The global Mycoplasma Pneumoniae ELISA Kits market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Mycoplasma Pneumoniae ELISA Kits competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Mycoplasma pneumoniae ELISA Kits are diagnostic tools designed to detect the presence of Mycoplasma pneumoniae, a bacterium that can cause respiratory tract infections in humans. These kits employ Enzyme-ed Immunosorbent Assay (ELISA) technology to identify specific antibodies produced by the immune system in response to the infection or to detect the bacterium directly in clinical samples. The kits are valuable for healthcare professionals in diagnosing mycoplasmal pneumonia and guiding appropriate treatment. Mycoplasma pneumoniae ELISA Kits are accurate, sensitive, and widely used in clinical laboratories.
The industry trend for Mycoplasma pneumoniae ELISA Kits is influenced by factors such as the increasing prevalence of respiratory infections, the growing awareness of mycoplasmal pneumonia, and the need for accurate diagnostic methods. Advances in ELISA technology continue to improve the sensitivity and specificity of these kits, making them more reliable for diagnosing Mycoplasma pneumoniae infections. Additionally, as healthcare systems focus on early detection and management of respiratory illnesses, the demand for Mycoplasma pneumonia ELISA Kits is expected to rise, contributing to the growth of the industry.
This report delivers a comprehensive overview of the global Mycoplasma Pneumoniae ELISA Kits market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Mycoplasma Pneumoniae ELISA Kits. The Mycoplasma Pneumoniae ELISA Kits market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Mycoplasma Pneumoniae ELISA Kits market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Mycoplasma Pneumoniae ELISA Kits manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Mycoplasma Pneumoniae ELISA Kits Market Report

Report Metric Details
Report Name Mycoplasma Pneumoniae ELISA Kits Market
Segment by Type
  • IgG
  • IgM
by Application
  • Laboratory
  • Hospital
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company MyBioSource, BosterBio, Abcam, Novus Biologicals, CUSABIO Technology, Creative Diagnostics, United States Biological, Biorbyt, DEMEDITEC Diagnostics, Abnova Corporation, Abbexa, Creative Biolabs, IBL, Aviva Systems Biology, American Research Products, Wuhan Fine Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Mycoplasma Pneumoniae ELISA Kits manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Mycoplasma Pneumoniae ELISA Kits sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Mycoplasma Pneumoniae ELISA Kits Market report?

Ans: The main players in the Mycoplasma Pneumoniae ELISA Kits Market are MyBioSource, BosterBio, Abcam, Novus Biologicals, CUSABIO Technology, Creative Diagnostics, United States Biological, Biorbyt, DEMEDITEC Diagnostics, Abnova Corporation, Abbexa, Creative Biolabs, IBL, Aviva Systems Biology, American Research Products, Wuhan Fine Biotech

What are the Application segmentation covered in the Mycoplasma Pneumoniae ELISA Kits Market report?

Ans: The Applications covered in the Mycoplasma Pneumoniae ELISA Kits Market report are Laboratory, Hospital, Others

What are the Type segmentation covered in the Mycoplasma Pneumoniae ELISA Kits Market report?

Ans: The Types covered in the Mycoplasma Pneumoniae ELISA Kits Market report are IgG, IgM

1 Mycoplasma Pneumoniae ELISA Kits Market Overview
1.1 Product Definition
1.2 Mycoplasma Pneumoniae ELISA Kits by Type
1.2.1 Global Mycoplasma Pneumoniae ELISA Kits Market Value by Type: 2025 vs 2032
1.2.2 IgG
1.2.3 IgM
1.3 Mycoplasma Pneumoniae ELISA Kits by Application
1.3.1 Global Mycoplasma Pneumoniae ELISA Kits Market Value by Application: 2025 vs 2032
1.3.2 Laboratory
1.3.3 Hospital
1.3.4 Others
1.4 Global Mycoplasma Pneumoniae ELISA Kits Market Size Estimates and Forecasts
1.4.1 Global Mycoplasma Pneumoniae ELISA Kits Revenue 2021–2032
1.4.2 Global Mycoplasma Pneumoniae ELISA Kits Sales 2021–2032
1.4.3 Global Mycoplasma Pneumoniae ELISA Kits Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Mycoplasma Pneumoniae ELISA Kits Market Competition by Manufacturers
2.1 Global Mycoplasma Pneumoniae ELISA Kits Sales Market Share by Manufacturers (2021–2026)
2.2 Global Mycoplasma Pneumoniae ELISA Kits Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Mycoplasma Pneumoniae ELISA Kits Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Mycoplasma Pneumoniae ELISA Kits, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Mycoplasma Pneumoniae ELISA Kits, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Mycoplasma Pneumoniae ELISA Kits, Product Types and Applications
2.7 Global Key Manufacturers of Mycoplasma Pneumoniae ELISA Kits, Date of Entry into the Industry
2.8 Global Mycoplasma Pneumoniae ELISA Kits Market Competitive Situation and Trends
2.8.1 Global Mycoplasma Pneumoniae ELISA Kits Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Mycoplasma Pneumoniae ELISA Kits Players Market Share by Revenue
2.8.3 Global Mycoplasma Pneumoniae ELISA Kits Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mycoplasma Pneumoniae ELISA Kits Market Scenario by Region
3.1 Global Mycoplasma Pneumoniae ELISA Kits Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Mycoplasma Pneumoniae ELISA Kits Sales by Region: 2021–2032
3.2.1 Global Mycoplasma Pneumoniae ELISA Kits Sales by Region: 2021–2026
3.2.2 Global Mycoplasma Pneumoniae ELISA Kits Sales by Region: 2027–2032
3.3 Global Mycoplasma Pneumoniae ELISA Kits Revenue by Region: 2021–2032
3.3.1 Global Mycoplasma Pneumoniae ELISA Kits Revenue by Region: 2021–2026
3.3.2 Global Mycoplasma Pneumoniae ELISA Kits Revenue by Region: 2027–2032
3.4 North America Mycoplasma Pneumoniae ELISA Kits Market Facts & Figures by Country
3.4.1 North America Mycoplasma Pneumoniae ELISA Kits Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Mycoplasma Pneumoniae ELISA Kits Sales by Country (2021–2032)
3.4.3 North America Mycoplasma Pneumoniae ELISA Kits Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mycoplasma Pneumoniae ELISA Kits Market Facts & Figures by Country
3.5.1 Europe Mycoplasma Pneumoniae ELISA Kits Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Mycoplasma Pneumoniae ELISA Kits Sales by Country (2021–2032)
3.5.3 Europe Mycoplasma Pneumoniae ELISA Kits Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mycoplasma Pneumoniae ELISA Kits Market Facts & Figures by Region
3.6.1 Asia Pacific Mycoplasma Pneumoniae ELISA Kits Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Mycoplasma Pneumoniae ELISA Kits Sales by Region (2021–2032)
3.6.3 Asia Pacific Mycoplasma Pneumoniae ELISA Kits Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Mycoplasma Pneumoniae ELISA Kits Market Facts & Figures by Country
3.7.1 Latin America Mycoplasma Pneumoniae ELISA Kits Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Mycoplasma Pneumoniae ELISA Kits Sales by Country (2021–2032)
3.7.3 Latin America Mycoplasma Pneumoniae ELISA Kits Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Mycoplasma Pneumoniae ELISA Kits Market Facts & Figures by Country
3.8.1 Middle East and Africa Mycoplasma Pneumoniae ELISA Kits Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Mycoplasma Pneumoniae ELISA Kits Sales by Country (2021–2032)
3.8.3 Middle East and Africa Mycoplasma Pneumoniae ELISA Kits Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mycoplasma Pneumoniae ELISA Kits Sales by Type (2021–2032)
4.1.1 Global Mycoplasma Pneumoniae ELISA Kits Sales by Type (2021–2026)
4.1.2 Global Mycoplasma Pneumoniae ELISA Kits Sales by Type (2027–2032)
4.1.3 Global Mycoplasma Pneumoniae ELISA Kits Sales Market Share by Type (2021–2032)
4.2 Global Mycoplasma Pneumoniae ELISA Kits Revenue by Type (2021–2032)
4.2.1 Global Mycoplasma Pneumoniae ELISA Kits Revenue by Type (2021–2026)
4.2.2 Global Mycoplasma Pneumoniae ELISA Kits Revenue by Type (2027–2032)
4.2.3 Global Mycoplasma Pneumoniae ELISA Kits Revenue Market Share by Type (2021–2032)
4.3 Global Mycoplasma Pneumoniae ELISA Kits Price by Type (2021–2032)
5 Segment by Application
5.1 Global Mycoplasma Pneumoniae ELISA Kits Sales by Application (2021–2032)
5.1.1 Global Mycoplasma Pneumoniae ELISA Kits Sales by Application (2021–2026)
5.1.2 Global Mycoplasma Pneumoniae ELISA Kits Sales by Application (2027–2032)
5.1.3 Global Mycoplasma Pneumoniae ELISA Kits Sales Market Share by Application (2021–2032)
5.2 Global Mycoplasma Pneumoniae ELISA Kits Revenue by Application (2021–2032)
5.2.1 Global Mycoplasma Pneumoniae ELISA Kits Revenue by Application (2021–2026)
5.2.2 Global Mycoplasma Pneumoniae ELISA Kits Revenue by Application (2027–2032)
5.2.3 Global Mycoplasma Pneumoniae ELISA Kits Revenue Market Share by Application (2021–2032)
5.3 Global Mycoplasma Pneumoniae ELISA Kits Price by Application (2021–2032)
6 Key Companies Profiled
6.1 MyBioSource
6.1.1 MyBioSource Company Information
6.1.2 MyBioSource Description and Business Overview
6.1.3 MyBioSource Mycoplasma Pneumoniae ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 MyBioSource Mycoplasma Pneumoniae ELISA Kits Product Portfolio
6.1.5 MyBioSource Recent Developments/Updates
6.2 BosterBio
6.2.1 BosterBio Company Information
6.2.2 BosterBio Description and Business Overview
6.2.3 BosterBio Mycoplasma Pneumoniae ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 BosterBio Mycoplasma Pneumoniae ELISA Kits Product Portfolio
6.2.5 BosterBio Recent Developments/Updates
6.3 Abcam
6.3.1 Abcam Company Information
6.3.2 Abcam Description and Business Overview
6.3.3 Abcam Mycoplasma Pneumoniae ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Abcam Mycoplasma Pneumoniae ELISA Kits Product Portfolio
6.3.5 Abcam Recent Developments/Updates
6.4 Novus Biologicals
6.4.1 Novus Biologicals Company Information
6.4.2 Novus Biologicals Description and Business Overview
6.4.3 Novus Biologicals Mycoplasma Pneumoniae ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Novus Biologicals Mycoplasma Pneumoniae ELISA Kits Product Portfolio
6.4.5 Novus Biologicals Recent Developments/Updates
6.5 CUSABIO Technology
6.5.1 CUSABIO Technology Company Information
6.5.2 CUSABIO Technology Description and Business Overview
6.5.3 CUSABIO Technology Mycoplasma Pneumoniae ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 CUSABIO Technology Mycoplasma Pneumoniae ELISA Kits Product Portfolio
6.5.5 CUSABIO Technology Recent Developments/Updates
6.6 Creative Diagnostics
6.6.1 Creative Diagnostics Company Information
6.6.2 Creative Diagnostics Description and Business Overview
6.6.3 Creative Diagnostics Mycoplasma Pneumoniae ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Creative Diagnostics Mycoplasma Pneumoniae ELISA Kits Product Portfolio
6.6.5 Creative Diagnostics Recent Developments/Updates
6.7 United States Biological
6.7.1 United States Biological Company Information
6.7.2 United States Biological Description and Business Overview
6.7.3 United States Biological Mycoplasma Pneumoniae ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 United States Biological Mycoplasma Pneumoniae ELISA Kits Product Portfolio
6.7.5 United States Biological Recent Developments/Updates
6.8 Biorbyt
6.8.1 Biorbyt Company Information
6.8.2 Biorbyt Description and Business Overview
6.8.3 Biorbyt Mycoplasma Pneumoniae ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Biorbyt Mycoplasma Pneumoniae ELISA Kits Product Portfolio
6.8.5 Biorbyt Recent Developments/Updates
6.9 DEMEDITEC Diagnostics
6.9.1 DEMEDITEC Diagnostics Company Information
6.9.2 DEMEDITEC Diagnostics Description and Business Overview
6.9.3 DEMEDITEC Diagnostics Mycoplasma Pneumoniae ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 DEMEDITEC Diagnostics Mycoplasma Pneumoniae ELISA Kits Product Portfolio
6.9.5 DEMEDITEC Diagnostics Recent Developments/Updates
6.10 Abnova Corporation
6.10.1 Abnova Corporation Company Information
6.10.2 Abnova Corporation Description and Business Overview
6.10.3 Abnova Corporation Mycoplasma Pneumoniae ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Abnova Corporation Mycoplasma Pneumoniae ELISA Kits Product Portfolio
6.10.5 Abnova Corporation Recent Developments/Updates
6.11 Abbexa
6.11.1 Abbexa Company Information
6.11.2 Abbexa Description and Business Overview
6.11.3 Abbexa Mycoplasma Pneumoniae ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Abbexa Mycoplasma Pneumoniae ELISA Kits Product Portfolio
6.11.5 Abbexa Recent Developments/Updates
6.12 Creative Biolabs
6.12.1 Creative Biolabs Company Information
6.12.2 Creative Biolabs Description and Business Overview
6.12.3 Creative Biolabs Mycoplasma Pneumoniae ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Creative Biolabs Mycoplasma Pneumoniae ELISA Kits Product Portfolio
6.12.5 Creative Biolabs Recent Developments/Updates
6.13 IBL
6.13.1 IBL Company Information
6.13.2 IBL Description and Business Overview
6.13.3 IBL Mycoplasma Pneumoniae ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 IBL Mycoplasma Pneumoniae ELISA Kits Product Portfolio
6.13.5 IBL Recent Developments/Updates
6.14 Aviva Systems Biology
6.14.1 Aviva Systems Biology Company Information
6.14.2 Aviva Systems Biology Description and Business Overview
6.14.3 Aviva Systems Biology Mycoplasma Pneumoniae ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Aviva Systems Biology Mycoplasma Pneumoniae ELISA Kits Product Portfolio
6.14.5 Aviva Systems Biology Recent Developments/Updates
6.15 American Research Products
6.15.1 American Research Products Company Information
6.15.2 American Research Products Description and Business Overview
6.15.3 American Research Products Mycoplasma Pneumoniae ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 American Research Products Mycoplasma Pneumoniae ELISA Kits Product Portfolio
6.15.5 American Research Products Recent Developments/Updates
6.16 Wuhan Fine Biotech
6.16.1 Wuhan Fine Biotech Company Information
6.16.2 Wuhan Fine Biotech Description and Business Overview
6.16.3 Wuhan Fine Biotech Mycoplasma Pneumoniae ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Wuhan Fine Biotech Mycoplasma Pneumoniae ELISA Kits Product Portfolio
6.16.5 Wuhan Fine Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mycoplasma Pneumoniae ELISA Kits Industry Chain Analysis
7.2 Mycoplasma Pneumoniae ELISA Kits Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mycoplasma Pneumoniae ELISA Kits Production Mode & Process Analysis
7.4 Mycoplasma Pneumoniae ELISA Kits Sales and Marketing
7.4.1 Mycoplasma Pneumoniae ELISA Kits Sales Channels
7.4.2 Mycoplasma Pneumoniae ELISA Kits Distributors
7.5 Mycoplasma Pneumoniae ELISA Kits Customer Analysis
8 Mycoplasma Pneumoniae ELISA Kits Market Dynamics
8.1 Mycoplasma Pneumoniae ELISA Kits Industry Trends
8.2 Mycoplasma Pneumoniae ELISA Kits Market Drivers
8.3 Mycoplasma Pneumoniae ELISA Kits Market Challenges
8.4 Mycoplasma Pneumoniae ELISA Kits Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Mycoplasma Pneumoniae ELISA Kits Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Mycoplasma Pneumoniae ELISA Kits Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Mycoplasma Pneumoniae ELISA Kits Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Mycoplasma Pneumoniae ELISA Kits Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Mycoplasma Pneumoniae ELISA Kits Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Mycoplasma Pneumoniae ELISA Kits Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Mycoplasma Pneumoniae ELISA Kits Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Mycoplasma Pneumoniae ELISA Kits Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Mycoplasma Pneumoniae ELISA Kits, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Mycoplasma Pneumoniae ELISA Kits, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Mycoplasma Pneumoniae ELISA Kits, Product Types and Applications
 Table 12. Global Key Manufacturers of Mycoplasma Pneumoniae ELISA Kits, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Mycoplasma Pneumoniae ELISA Kits Companies by Tier (Tier 1, Tier 2, Tier 3), based on Mycoplasma Pneumoniae ELISA Kits Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Mycoplasma Pneumoniae ELISA Kits Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Mycoplasma Pneumoniae ELISA Kits Sales by Region (K Units), 2021–2026
 Table 18. Global Mycoplasma Pneumoniae ELISA Kits Sales Market Share by Region (2021–2026)
 Table 19. Global Mycoplasma Pneumoniae ELISA Kits Sales by Region (K Units), 2027–2032
 Table 20. Global Mycoplasma Pneumoniae ELISA Kits Sales Market Share by Region (2027–2032)
 Table 21. Global Mycoplasma Pneumoniae ELISA Kits Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Mycoplasma Pneumoniae ELISA Kits Revenue Market Share by Region (2021–2026)
 Table 23. Global Mycoplasma Pneumoniae ELISA Kits Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Mycoplasma Pneumoniae ELISA Kits Revenue Market Share by Region (2027–2032)
 Table 25. North America Mycoplasma Pneumoniae ELISA Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Mycoplasma Pneumoniae ELISA Kits Sales by Country (K Units), 2021–2026
 Table 27. North America Mycoplasma Pneumoniae ELISA Kits Sales by Country (K Units), 2027–2032
 Table 28. North America Mycoplasma Pneumoniae ELISA Kits Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Mycoplasma Pneumoniae ELISA Kits Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Mycoplasma Pneumoniae ELISA Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Mycoplasma Pneumoniae ELISA Kits Sales by Country (K Units), 2021–2026
 Table 32. Europe Mycoplasma Pneumoniae ELISA Kits Sales by Country (K Units), 2027–2032
 Table 33. Europe Mycoplasma Pneumoniae ELISA Kits Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Mycoplasma Pneumoniae ELISA Kits Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Mycoplasma Pneumoniae ELISA Kits Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Mycoplasma Pneumoniae ELISA Kits Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Mycoplasma Pneumoniae ELISA Kits Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Mycoplasma Pneumoniae ELISA Kits Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Mycoplasma Pneumoniae ELISA Kits Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Mycoplasma Pneumoniae ELISA Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Mycoplasma Pneumoniae ELISA Kits Sales by Country (K Units), 2021–2026
 Table 42. Latin America Mycoplasma Pneumoniae ELISA Kits Sales by Country (K Units), 2027–2032
 Table 43. Latin America Mycoplasma Pneumoniae ELISA Kits Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Mycoplasma Pneumoniae ELISA Kits Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Mycoplasma Pneumoniae ELISA Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Mycoplasma Pneumoniae ELISA Kits Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Mycoplasma Pneumoniae ELISA Kits Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Mycoplasma Pneumoniae ELISA Kits Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Mycoplasma Pneumoniae ELISA Kits Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Mycoplasma Pneumoniae ELISA Kits Sales (K Units) by Type (2021–2026)
 Table 51. Global Mycoplasma Pneumoniae ELISA Kits Sales (K Units) by Type (2027–2032)
 Table 52. Global Mycoplasma Pneumoniae ELISA Kits Sales Market Share by Type (2021–2026)
 Table 53. Global Mycoplasma Pneumoniae ELISA Kits Sales Market Share by Type (2027–2032)
 Table 54. Global Mycoplasma Pneumoniae ELISA Kits Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Mycoplasma Pneumoniae ELISA Kits Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Mycoplasma Pneumoniae ELISA Kits Revenue Market Share by Type (2021–2026)
 Table 57. Global Mycoplasma Pneumoniae ELISA Kits Revenue Market Share by Type (2027–2032)
 Table 58. Global Mycoplasma Pneumoniae ELISA Kits Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Mycoplasma Pneumoniae ELISA Kits Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Mycoplasma Pneumoniae ELISA Kits Sales (K Units) by Application (2021–2026)
 Table 61. Global Mycoplasma Pneumoniae ELISA Kits Sales (K Units) by Application (2027–2032)
 Table 62. Global Mycoplasma Pneumoniae ELISA Kits Sales Market Share by Application (2021–2026)
 Table 63. Global Mycoplasma Pneumoniae ELISA Kits Sales Market Share by Application (2027–2032)
 Table 64. Global Mycoplasma Pneumoniae ELISA Kits Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Mycoplasma Pneumoniae ELISA Kits Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Mycoplasma Pneumoniae ELISA Kits Revenue Market Share by Application (2021–2026)
 Table 67. Global Mycoplasma Pneumoniae ELISA Kits Revenue Market Share by Application (2027–2032)
 Table 68. Global Mycoplasma Pneumoniae ELISA Kits Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Mycoplasma Pneumoniae ELISA Kits Price (US$/Unit) by Application (2027–2032)
 Table 70. MyBioSource Company Information
 Table 71. MyBioSource Description and Business Overview
 Table 72. MyBioSource Mycoplasma Pneumoniae ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. MyBioSource Mycoplasma Pneumoniae ELISA Kits Product
 Table 74. MyBioSource Recent Developments/Updates
 Table 75. BosterBio Company Information
 Table 76. BosterBio Description and Business Overview
 Table 77. BosterBio Mycoplasma Pneumoniae ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. BosterBio Mycoplasma Pneumoniae ELISA Kits Product
 Table 79. BosterBio Recent Developments/Updates
 Table 80. Abcam Company Information
 Table 81. Abcam Description and Business Overview
 Table 82. Abcam Mycoplasma Pneumoniae ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Abcam Mycoplasma Pneumoniae ELISA Kits Product
 Table 84. Abcam Recent Developments/Updates
 Table 85. Novus Biologicals Company Information
 Table 86. Novus Biologicals Description and Business Overview
 Table 87. Novus Biologicals Mycoplasma Pneumoniae ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Novus Biologicals Mycoplasma Pneumoniae ELISA Kits Product
 Table 89. Novus Biologicals Recent Developments/Updates
 Table 90. CUSABIO Technology Company Information
 Table 91. CUSABIO Technology Description and Business Overview
 Table 92. CUSABIO Technology Mycoplasma Pneumoniae ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. CUSABIO Technology Mycoplasma Pneumoniae ELISA Kits Product
 Table 94. CUSABIO Technology Recent Developments/Updates
 Table 95. Creative Diagnostics Company Information
 Table 96. Creative Diagnostics Description and Business Overview
 Table 97. Creative Diagnostics Mycoplasma Pneumoniae ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Creative Diagnostics Mycoplasma Pneumoniae ELISA Kits Product
 Table 99. Creative Diagnostics Recent Developments/Updates
 Table 100. United States Biological Company Information
 Table 101. United States Biological Description and Business Overview
 Table 102. United States Biological Mycoplasma Pneumoniae ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. United States Biological Mycoplasma Pneumoniae ELISA Kits Product
 Table 104. United States Biological Recent Developments/Updates
 Table 105. Biorbyt Company Information
 Table 106. Biorbyt Description and Business Overview
 Table 107. Biorbyt Mycoplasma Pneumoniae ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Biorbyt Mycoplasma Pneumoniae ELISA Kits Product
 Table 109. Biorbyt Recent Developments/Updates
 Table 110. DEMEDITEC Diagnostics Company Information
 Table 111. DEMEDITEC Diagnostics Description and Business Overview
 Table 112. DEMEDITEC Diagnostics Mycoplasma Pneumoniae ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. DEMEDITEC Diagnostics Mycoplasma Pneumoniae ELISA Kits Product
 Table 114. DEMEDITEC Diagnostics Recent Developments/Updates
 Table 115. Abnova Corporation Company Information
 Table 116. Abnova Corporation Description and Business Overview
 Table 117. Abnova Corporation Mycoplasma Pneumoniae ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Abnova Corporation Mycoplasma Pneumoniae ELISA Kits Product
 Table 119. Abnova Corporation Recent Developments/Updates
 Table 120. Abbexa Company Information
 Table 121. Abbexa Description and Business Overview
 Table 122. Abbexa Mycoplasma Pneumoniae ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Abbexa Mycoplasma Pneumoniae ELISA Kits Product
 Table 124. Abbexa Recent Developments/Updates
 Table 125. Creative Biolabs Company Information
 Table 126. Creative Biolabs Description and Business Overview
 Table 127. Creative Biolabs Mycoplasma Pneumoniae ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Creative Biolabs Mycoplasma Pneumoniae ELISA Kits Product
 Table 129. Creative Biolabs Recent Developments/Updates
 Table 130. IBL Company Information
 Table 131. IBL Description and Business Overview
 Table 132. IBL Mycoplasma Pneumoniae ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. IBL Mycoplasma Pneumoniae ELISA Kits Product
 Table 134. IBL Recent Developments/Updates
 Table 135. Aviva Systems Biology Company Information
 Table 136. Aviva Systems Biology Description and Business Overview
 Table 137. Aviva Systems Biology Mycoplasma Pneumoniae ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Aviva Systems Biology Mycoplasma Pneumoniae ELISA Kits Product
 Table 139. Aviva Systems Biology Recent Developments/Updates
 Table 140. American Research Products Company Information
 Table 141. American Research Products Description and Business Overview
 Table 142. American Research Products Mycoplasma Pneumoniae ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. American Research Products Mycoplasma Pneumoniae ELISA Kits Product
 Table 144. American Research Products Recent Developments/Updates
 Table 145. Wuhan Fine Biotech Company Information
 Table 146. Wuhan Fine Biotech Description and Business Overview
 Table 147. Wuhan Fine Biotech Mycoplasma Pneumoniae ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. Wuhan Fine Biotech Mycoplasma Pneumoniae ELISA Kits Product
 Table 149. Wuhan Fine Biotech Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Mycoplasma Pneumoniae ELISA Kits Distributors List
 Table 153. Mycoplasma Pneumoniae ELISA Kits Customers List
 Table 154. Mycoplasma Pneumoniae ELISA Kits Market Trends
 Table 155. Mycoplasma Pneumoniae ELISA Kits Market Drivers
 Table 156. Mycoplasma Pneumoniae ELISA Kits Market Challenges
 Table 157. Mycoplasma Pneumoniae ELISA Kits Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Mycoplasma Pneumoniae ELISA Kits
 Figure 2. Global Mycoplasma Pneumoniae ELISA Kits Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Mycoplasma Pneumoniae ELISA Kits Market Share by Type: 2025 & 2032
 Figure 4. IgG Product Picture
 Figure 5. IgM Product Picture
 Figure 6. Global Mycoplasma Pneumoniae ELISA Kits Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Mycoplasma Pneumoniae ELISA Kits Market Share by Application: 2025 & 2032
 Figure 8. Laboratory
 Figure 9. Hospital
 Figure 10. Others
 Figure 11. Global Mycoplasma Pneumoniae ELISA Kits Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Mycoplasma Pneumoniae ELISA Kits Market Size (US$ Million), 2021–2032
 Figure 13. Global Mycoplasma Pneumoniae ELISA Kits Sales (K Units), 2021–2032
 Figure 14. Global Mycoplasma Pneumoniae ELISA Kits Average Price (US$/Unit), 2021–2032
 Figure 15. Mycoplasma Pneumoniae ELISA Kits Report Years Considered
 Figure 16. Mycoplasma Pneumoniae ELISA Kits Sales Share by Manufacturers in 2025
 Figure 17. Global Mycoplasma Pneumoniae ELISA Kits Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Mycoplasma Pneumoniae ELISA Kits Players: Market Share by Revenue in Mycoplasma Pneumoniae ELISA Kits in 2025
 Figure 19. Mycoplasma Pneumoniae ELISA Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Mycoplasma Pneumoniae ELISA Kits Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Mycoplasma Pneumoniae ELISA Kits Sales Market Share by Country (2021–2032)
 Figure 22. North America Mycoplasma Pneumoniae ELISA Kits Revenue Market Share by Country (2021–2032)
 Figure 23. United States Mycoplasma Pneumoniae ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Mycoplasma Pneumoniae ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Mycoplasma Pneumoniae ELISA Kits Sales Market Share by Country (2021–2032)
 Figure 26. Europe Mycoplasma Pneumoniae ELISA Kits Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Mycoplasma Pneumoniae ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Mycoplasma Pneumoniae ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Mycoplasma Pneumoniae ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Mycoplasma Pneumoniae ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Mycoplasma Pneumoniae ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Mycoplasma Pneumoniae ELISA Kits Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Mycoplasma Pneumoniae ELISA Kits Revenue Market Share by Region (2021–2032)
 Figure 34. China Mycoplasma Pneumoniae ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Mycoplasma Pneumoniae ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Mycoplasma Pneumoniae ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Mycoplasma Pneumoniae ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Mycoplasma Pneumoniae ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Mycoplasma Pneumoniae ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Mycoplasma Pneumoniae ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Mycoplasma Pneumoniae ELISA Kits Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Mycoplasma Pneumoniae ELISA Kits Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Mycoplasma Pneumoniae ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Mycoplasma Pneumoniae ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Mycoplasma Pneumoniae ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Mycoplasma Pneumoniae ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Mycoplasma Pneumoniae ELISA Kits Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Mycoplasma Pneumoniae ELISA Kits Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Mycoplasma Pneumoniae ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Mycoplasma Pneumoniae ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Mycoplasma Pneumoniae ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Mycoplasma Pneumoniae ELISA Kits by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Mycoplasma Pneumoniae ELISA Kits by Type (2021–2032)
 Figure 54. Global Mycoplasma Pneumoniae ELISA Kits Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Mycoplasma Pneumoniae ELISA Kits by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Mycoplasma Pneumoniae ELISA Kits by Application (2021–2032)
 Figure 57. Global Mycoplasma Pneumoniae ELISA Kits Price (US$/Unit) by Application (2021–2032)
 Figure 58. Mycoplasma Pneumoniae ELISA Kits Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI